HB1349, titled the “Women’s Protection in Telehealth Act,” would amend the Social Security Act to require exclusion from Medicare of any individual or entity that, on or after enactment, prescribes, administers, dispenses, or furnishes an abortion-inducing drug unless strict in-person conditions are met. Under the bill, the provider must be a physician, physically examine the patient, be physically present in the same room when the drug is taken or administered, and schedule an in-person follow-up visit within 14 days.
The bill also defines “abortion-inducing drug” broadly to include any medicine or substance used with the intent to terminate a clinically diagnosable pregnancy, including off-label use, and it incorporates the federal criminal code definition of “unborn child.” It makes the exclusion permanent and removes the usual administrative relief provisions that can apply to other Medicare exclusions, signaling a more severe and lasting penalty for covered conduct.
Impact
The bill would amend Section 1128 of the Social Security Act, expanding Medicare exclusion authority to create a new mandatory and permanent exclusion category for providers involved in certain abortion-drug services. It would affect physicians, clinics, telehealth providers, and other entities that furnish medication abortion services, particularly those using remote prescribing or dispensing models. By tying the penalty to Medicare participation, the bill would alter provider eligibility for federal health program participation and could have broader operational effects on reproductive-health and telehealth practices.
Sentiment
The available record shows the bill was introduced by Republican sponsors and referred to committee, with no recorded votes or committee transcript discussion provided. Based on the bill’s sponsors and subject matter, the measure appears to be aligned with anti-abortion policy goals and framed as a protection for women in telehealth. Because there is no recorded debate in the supplied materials, there is no direct evidence of bipartisan support or opposition in committee, but the proposal’s restrictions suggest it would likely be viewed favorably by abortion opponents and negatively by abortion-rights advocates and telehealth providers.
Contention
The main point of contention is the bill’s restriction on medication abortion, especially its requirement for an in-person physician examination and same-room administration, which would sharply limit telehealth and remote-care models. Another likely dispute is the bill’s broad definition of abortion-inducing drugs and its use of the term “unborn child,” which may be seen as expansive and ideologically loaded. The permanent exclusion from Medicare, along with the removal of standard relief mechanisms, is also likely to be controversial because it imposes a harsher sanction than typical exclusion provisions.